Rhythm(RYTM) - 2025 Q4 - Earnings Call Transcript

Rhythm Pharmaceuticals (NasdaqGM:RYTM) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsCorinne Johnson - Managing DirectorDave Connolly - Head of Investor Relations and Corporate CommunicationsDavid Meeker - Chairman, CEO, and PresidentDerek Archila - Managing Director and Co-Head of Therapeutics ResearchHunter Smith - CFOJennifer Lee - EVP and Head of North AmericaJon Wolleben - Managing DirectorTazeen Ahmad - Managing DirectorYann Mazabraud - EVP and Head of InternationalConference ...